MRVL vs. KRYS
MRVL (Marvell Technology, Inc.) and KRYS (Krystal Biotech, Inc.) are both stocks. MRVL operates in Semiconductors (Technology), while KRYS operates in Biotechnology (Healthcare). Over the past 5 years, MRVL returned 42.37%/yr vs 35.77%/yr for KRYS. At a 0.28 correlation, their price movements are largely independent.
Performance
MRVL vs. KRYS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRVL achieves a 240.32% return, which is significantly higher than KRYS's 22.40% return.
MRVL
- 1D
- 9.63%
- 1M
- 69.78%
- YTD
- 240.32%
- 6M
- 214.35%
- 1Y
- 323.75%
- 3Y*
- 69.41%
- 5Y*
- 42.37%
- 10Y*
- 41.26%
KRYS
- 1D
- 0.25%
- 1M
- -1.29%
- YTD
- 22.40%
- 6M
- 28.93%
- 1Y
- 120.36%
- 3Y*
- 32.77%
- 5Y*
- 35.77%
- 10Y*
- —
MRVL vs. KRYS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MRVL Marvell Technology, Inc. | 240.32% | -22.82% | 83.79% | 63.68% | -57.48% | 84.62% | 80.25% | 65.74% | -23.62% | 19.00% |
KRYS Krystal Biotech, Inc. | 22.40% | 57.37% | 26.28% | 56.60% | 13.25% | 16.58% | 8.34% | 166.51% | 97.53% | 0.19% |
Correlation
The correlation between MRVL and KRYS is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2017 | 0.28 |
The correlation between MRVL and KRYS shifts across timeframes, from 0.14 (1 year) to 0.30 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
MRVL:
$258.03B
KRYS:
$9.21B
MRVL:
$2.90
KRYS:
$7.50
MRVL:
99.74
KRYS:
40.24
MRVL:
0.18
KRYS:
0.10
MRVL:
28.91
KRYS:
21.70
MRVL:
14.17
KRYS:
7.21
MRVL:
$8.72B
KRYS:
$417.30M
MRVL:
$4.41B
KRYS:
$387.24M
MRVL:
$4.27B
KRYS:
$185.45M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRVL vs. KRYS — Risk / Return Rank
MRVL
KRYS
MRVL vs. KRYS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Marvell Technology, Inc. (MRVL) and Krystal Biotech, Inc. (KRYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MRVL | KRYS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +0.86 | ||
| Omega ratioGain probability vs. loss probability | 1.59 | 1.47 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 12.37 | 7.59 | +4.78 |
| Martin ratioReturn relative to average drawdown | 28.64 | 19.64 | +9.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MRVL | KRYS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.70 | 3.12 | +1.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.69 | 0.47 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.80 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.23 | 0.63 | -0.40 |
Drawdowns
MRVL vs. KRYS - Drawdown Comparison
The maximum MRVL drawdown since its inception was -91.60%, which is greater than KRYS's maximum drawdown of -53.42%. Use the drawdown chart below to compare losses from any high point for MRVL and KRYS.
Loading charts...
Drawdown Indicators
| MRVL | KRYS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.60% | -53.42% | -38.18% |
Max Drawdown (1Y)Largest decline over 1 year | -26.36% | -15.94% | -10.42% |
Max Drawdown (3Y)Largest decline over 3 years | -60.79% | -42.26% | -18.53% |
Max Drawdown (5Y)Largest decline over 5 years | -61.88% | -44.55% | -17.33% |
Max Drawdown (10Y)Largest decline over 10 years | -61.88% | — | — |
Current DrawdownCurrent decline from peak | -8.72% | -4.60% | -4.12% |
Average DrawdownAverage peak-to-trough decline | -46.77% | -16.20% | -30.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.37% | 6.15% | +5.22% |
Volatility
MRVL vs. KRYS - Volatility Comparison
Marvell Technology, Inc. (MRVL) has a higher volatility of 38.50% compared to Krystal Biotech, Inc. (KRYS) at 10.25%. This indicates that MRVL's price experiences larger fluctuations and is considered to be riskier than KRYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRVL | KRYS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 38.50% | 10.25% | +28.25% |
Volatility (6M)Calculated over the trailing 6-month period | 54.32% | 27.29% | +27.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.56% | 38.91% | +30.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.51% | 76.38% | -14.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.77% | 74.19% | -22.42% |
Dividends
MRVL vs. KRYS - Dividend Comparison
MRVL's dividend yield for the trailing twelve months is around 0.08%, while KRYS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KRYS Krystal Biotech, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRVL Marvell Technology, Inc. | 0.08% | 0.28% | 0.22% | 0.40% | 0.65% | 0.21% | 0.50% | 0.90% | 1.48% | 1.12% | 1.73% | 2.72% |
Financials
MRVL vs. KRYS - Financials Comparison
This section allows you to compare key financial metrics between Marvell Technology, Inc. and Krystal Biotech, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRVL vs. KRYS - Profitability Comparison
MRVL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported a gross profit of 1.26B and revenue of 2.42B. Therefore, the gross margin over that period was 52.2%.
KRYS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported a gross profit of 110.03M and revenue of 116.36M. Therefore, the gross margin over that period was 94.6%.
MRVL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported an operating income of 339.40M and revenue of 2.42B, resulting in an operating margin of 14.0%.
KRYS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported an operating income of 53.69M and revenue of 116.36M, resulting in an operating margin of 46.1%.
MRVL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Marvell Technology, Inc. reported a net income of 34.50M and revenue of 2.42B, resulting in a net margin of 1.4%.
KRYS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Krystal Biotech, Inc. reported a net income of 55.93M and revenue of 116.36M, resulting in a net margin of 48.1%.
Frequently Asked Questions
MRVL and KRYS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRVL has higher volatility (38.50%) compared to KRYS (10.25%). In terms of maximum drawdown, MRVL dropped -91.60% vs KRYS's -53.42%.
MRVL currently has the higher Sharpe Ratio (4.70 vs 3.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRVL and KRYS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer